Skip to content

Duramesh™ vs Polydioxanone Suture for Laparotomy Closure

A Prospective Randomized Controlled Trial Comparing Duramesh™ With Polydioxanone Suture for Laparotomy Closure

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05804136
Acronym
MOMENTUM RCT
Enrollment
230
Registered
2023-04-07
Start date
2023-03-31
Completion date
2027-07-31
Last updated
2025-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparotomy Closure After Abdominal Surgery

Brief summary

This study is intended to demonstrate the non-inferiority of a Duramesh closure as compared to a polydioxanone closure for early surgical site events (SSE) (\< 1 month), and Duramesh superiority to polydioxanone for the development of incisional hernia by 1 year for a laparotomy closure.

Detailed description

This clinical investigation is designed to compare laparotomy closure with Duramesh to closure using PDS. The primary outcome is SSE that occurs within 1 month after surgery. Secondary outcomes that will be studied include device performance and technical success of the index-procedure, hernia occurrence/recurrence noted at 12 months after surgery, SSE and re-interventions that occur within 12 months of surgery, pain, implant palpability/sensation, surgeon and patient satisfaction, and quality of life.

Interventions

DEVICEDuramesh

Laparotomy closure with Duramesh

DEVICEPolydioxanone suture

Laparotomy closure with standard PDS

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Investigator-initiated, academic, prospective, randomized-controlled, interventional, monocenter study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or greater * Abdominal laparotomy 5 cm in length or greater, either midline or non-midline * Isolated ostomy site takedown with or without parastomal hernia * Patient accepts participation and gives informed consent * Patient and investigator signed and dated the informed consent form prior to the index-procedure

Exclusion criteria

* Pregnancy * Presence of clinically recognized hernia at laparotomy site (parastomal hernia noted at time of ostomy site takedown is not an exclusion criterion. Subclinical incidental small hernia \< 1 cm in greatest dimension found at the time of a laparotomy is not an automatic exclusion criterion) * Prior hernia repair at laparotomy site * Use of planar mesh in addition to sutures for closure * CDC IV dirty or infected wound that causes the surgeon to leave the abdominal wall or skin incision open * Life expectancy less than 1 year * Patient is unable / unwilling to provide informed consent * Patient is unable to comply with the protocol or proposed follow-up visits * Patient is enrolled in another abdominal wall study

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome is SSE that occurs within 1 month after surgery.1 monthThis study is intended to demonstrate the non-inferiority of a Duramesh closure as compared to a polydioxanone closure for early surgical site events (SSE) (\< 1 month). SSE include: Seroma, Hematoma, Soft tissue breakdown, Fascial dehiscence, Cellulitis, Suture granuloma, Chronic draining sinus, Enterocutaneous fistula, Superficial, deep and organ/space infections, Other

Secondary

MeasureTime frameDescription
SSE within the first 12 months after repair.12 monthsSSE include: Surgical incision wound (this does NOT include a less than 5 mm scar-related superficial wound due to scar instability), Chronic draining sinus, Enterocutaneous fistula, Persistent seroma or fluid collection between the abdominal wall incision and the skin but not draining, Other
Clinical hernia occurrence/recurrence within 12 months after repair.12 monthsThis study is intended to demonstrate Duramesh superiority to polydioxanone for the development of incisional hernia by 1 year for a laparotomy closure.
Return to the operating room (re-interventions) within 12 months for device related issue.12 monthsRe-interventions are defined as: All re-interventions relating to abdominal wall closure complications or abdominal re-exploration.
Surgeon satisfaction at 1-month follow-up using the 5-point smiley face scale.1 month
Technical success of index-procedure.ProcedureTechnical success is defined as successful abdominal wall closure without unexpected difficulties.
Device performance using the 5-point smiley face scale.Procedure
Surgeon satisfaction at index-procedure using the 5-point smiley face scale.Procedure
Pain of the surgical incision using 11 point Numeric Pain Rating Scale (NRS) at 12-months follow-up.12 monthsThe pain NRS is a single 11-point numeric scale with 0 representing one pain extreme (e.g., no pain) and 10 representing the other pain extreme (e.g., pain as bad as you can imagine and worst pain imaginable). The NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondents selects a whole number (0 to 10 integers) that best reflects the intensity of their pain. Pain will be scored in rest and with activity. Activity is defined as activity of daily living, e.g. walking, driving, getting into a car, setting the dinner table, doing the laundry, etc.
Palpability/sensation of suture used for the repair at 12-months follow-up.12 monthsAssessment whether the patient can feel the suture.
Quality of life using Short Form 12 (SF-12) health survey at 12-months follow-up.12 monthsThe SF-12 Health Survey is a 12-item, patient-reported survey of patient health.
Patient satisfaction at 1-month follow-up 5-point smiley face scale.1 month
Patient satisfaction at 12-months follow-up 5-point smiley face scale.12 months
Pain of the surgical incision using 11 point Numeric Pain Rating Scale (NRS) at 1-month follow-up.1 monthThe pain NRS is a single 11-point numeric scale with 0 representing one pain extreme (e.g., no pain) and 10 representing the other pain extreme (e.g., pain as bad as you can imagine and worst pain imaginable). The NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondents selects a whole number (0 to 10 integers) that best reflects the intensity of their pain. Pain will be scored in rest and with activity. Activity is defined as activity of daily living, e.g. walking, driving, getting into a car, setting the dinner table, doing the laundry, etc.

Countries

Belgium

Contacts

Primary ContactDorien Haesen, PhD
dorien.haesen@archerresearch.eu+32 11 28 69 48

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026